Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFX.L Regulatory News (AFX)

  • There is currently no data for AFX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Growth Share Scheme Extended from 3 to 5 Years

5 Sep 2017 07:00

RNS Number : 7930P
Alpha FX Group PLC
05 September 2017
 

5 September 2017

 

Alpha FX Group plc

("Alpha", the "Company" or the "Group")

Growth Share Scheme Extended from 3 to 5 Years

Alpha FX (AIM:AFX) today wishes to update shareholders with regards to changes in the Company's Growth Share Scheme. At IPO the Company implemented a Growth Share Scheme ("Growth Share Scheme"), under which B ordinary shares in the Company's subsidiary ("B Shares") may be issued to full-time employees of the Group. The Growth Share Scheme is administered and managed by the Board of Alpha.

The B Shares contain a put option, such that, when and to the extent vested, they can be converted into ordinary shares in the Company. Under the original terms of the Growth Share Scheme, the B Shares allotted to participants would vest in three equal tranches, occurring annually, starting on 31 December 2017 until 31 December 2019. Vesting would require 30 per cent. revenue growth per year, meaning that full vesting would require three year compound growth of 120 per cent.

Following consultation with participants in the Growth Share Scheme, the length of the Scheme has been extended, with the B Shares vesting in five equal tranches, occurring annually, starting on 31 December 2017 until 31 December 2021. The requirements for revenue growth in the first three years remain the same, namely 30 per cent. per year, whilst vesting in years four and five require 20 per cent. revenue growth per year. All other details of the Growth Share Scheme remain as set out in the Company's Admission Document.

The changes to the Growth Share Scheme were considered and approved by the Remuneration Committee (Lisa Gordon acting as Chairman).

 

Enquiries:

 

Alpha FX Group plc via Alma PR

Lisa Gordon, Chairman of Remuneration Committee

Clive Kahn

 

Liberum Capital Limited (Nominated Adviser and Sole Broker) Tel: +44 (0) 20 3100 2000

Neil Patel

Richard Bootle

Dominik Götzenberger

 

Alma PR (Financial Public Relations) Tel: 07580 216 203

Josh Royston

Rebecca Sanders-Hewett

Helena Bogle

 

 

 

Market Abuse Regulation

This announcement is released by Alpha FX Group plc and contains inside information for the purposes of the Market Abuse Regulation (EU) 596/2014 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR. The person who arranged for the release of this announcement on behalf of Alpha FX Group plc was Tim Kidd, Chief Financial Officer.

 

 

Notes to Editors

Alpha is a UK-based corporate foreign exchange service provider focused on managing exchange rate risk for UK corporates that trade internationally. The Company's primary client base consists of medium sized corporates that have a requirement to convert currency for a commercial purpose, such as buying or selling goods and services overseas, repatriating profits, or expatriating payroll. Since it was incorporated in 2010, Alpha has been able to build and retain a high-quality client base that includes brands such as ASOS, Holland & Barrett and Global Data.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLAATISIID
Date   Source Headline
19th Dec 20224:02 pmRNSName Change to Alpha Group International
16th Dec 20227:00 amRNSUpdate on Name Change
22nd Nov 20222:04 pmRNSHolding(s) in Company
22nd Nov 202211:00 amRNSResult of General Meeting
10th Nov 20224:53 pmRNSHolding(s) in Company
4th Nov 20227:00 amRNSNotice of GM
4th Nov 20227:00 amRNSF Share Award
26th Oct 20224:22 pmRNSHolding(s) in Company
25th Oct 20225:47 pmRNSHolding(s) in Company
21st Oct 20227:00 amRNSTrading Update
19th Oct 20224:30 pmRNSHolding(s) in Company
19th Oct 20227:00 amRNSAppointment of CFO
18th Oct 20225:41 pmRNSHolding(s) in Company
10th Oct 20227:00 amRNSLaunch of New Website
14th Sep 20228:17 amRNSDirector/PDMR Shareholding
12th Sep 20225:20 pmRNSDirector/PDMR Shareholding
5th Sep 20227:00 amRNSInterim Report
21st Jul 20227:00 amRNSTrading Update
30th Jun 20227:00 amRNSTotal Voting Rights
22nd Jun 20227:00 amRNSGrowth Share Schemes and PDMR Dealing
6th Jun 20224:18 pmRNSHolding(s) in Company
31st May 20227:00 amRNSTotal Voting Rights
27th May 20224:25 pmRNSHolding(s) in Company
20th May 20224:56 pmRNSHolding(s) in Company
9th May 20223:51 pmRNSDirector/PDMR Shareholding
5th May 202211:27 amRNSResult of AGM
3rd May 20227:00 amRNSTotal Voting Rights
20th Apr 20222:21 pmRNSDirector/PDMR Shareholding
12th Apr 20227:00 amRNSNotice of AGM & Posting of Annual Report
6th Apr 20225:53 pmRNSHolding(s) in Company
6th Apr 20227:00 amRNSPDMR Shareholding
5th Apr 20227:00 amRNSTrading with Key Norwegian Client Recommences
31st Mar 20227:00 amRNSTotal Voting Rights
22nd Mar 20222:24 pmRNSHolding(s) in Company
22nd Mar 20227:00 amRNSBlock Admission Application
16th Mar 20224:13 pmRNSDirector/PDMR Shareholdings
16th Mar 20224:07 pmRNSIssue of Shares, Director/PDMR Shareholdings, TVR
16th Mar 20222:06 pmRNSSecond Price Monitoring Extn
16th Mar 20222:00 pmRNSPrice Monitoring Extension
16th Mar 20229:05 amRNSSecond Price Monitoring Extn
16th Mar 20229:00 amRNSPrice Monitoring Extension
16th Mar 20227:00 amRNSFull Year Results
14th Feb 20221:52 pmRNSHolding(s) in Company
10th Feb 20224:41 pmRNSSecond Price Monitoring Extn
10th Feb 20224:35 pmRNSPrice Monitoring Extension
10th Feb 20222:05 pmRNSSecond Price Monitoring Extn
10th Feb 20222:00 pmRNSPrice Monitoring Extension
19th Jan 20227:00 amRNSTrading Update and Intended Board Change
13th Jan 20227:00 amRNSAppointment of MD for new Luxembourg office
23rd Dec 20217:00 amRNSRevision to APS Employee Share Ownership Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.